iBio (IBIO) Notes Payables (2020 - 2025)
Historic Notes Payables for iBio (IBIO) over the last 6 years, with Q3 2025 value amounting to $706000.0.
- iBio's Notes Payables rose 21101.32% to $706000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $706000.0, marking a year-over-year increase of 21101.32%. This contributed to the annual value of $766000.0 for FY2025, which is 25137.61% up from last year.
- According to the latest figures from Q3 2025, iBio's Notes Payables is $706000.0, which was up 21101.32% from $766000.0 recorded in Q2 2025.
- Over the past 5 years, iBio's Notes Payables peaked at $22.2 million during Q3 2022, and registered a low of $218000.0 during Q2 2024.
- Moreover, its 5-year median value for Notes Payables was $6.7 million (2023), whereas its average is $8.1 million.
- Per our database at Business Quant, iBio's Notes Payables skyrocketed by 359350.0% in 2022 and then plummeted by 9831.49% in 2024.
- iBio's Notes Payables (Quarter) stood at $600000.0 in 2021, then soared by 2568.5% to $16.0 million in 2022, then decreased by 20.96% to $12.7 million in 2023, then plummeted by 95.25% to $601000.0 in 2024, then increased by 17.47% to $706000.0 in 2025.
- Its Notes Payables stands at $706000.0 for Q3 2025, versus $766000.0 for Q2 2025 and $824000.0 for Q1 2025.